Cargando…

Rapid deterioration in quality of life during interleukin-2- and α-interferon-based home therapy of renal cell carcinoma is associated with a good outcome

We conducted a prospective quality-of-life analysis during outpatient immunotherapy in 22 patients with progressive metastatic renal cell carcinoma (RCC) treated with subcutaneous interferon-α2a and subcutaneous interleukin-2. Patients' quality of life was assessed by the European Organization...

Descripción completa

Detalles Bibliográficos
Autores principales:	Atzpodien, J, Küchler, Th, Wandert, T, Reitz, M
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2003
Materias:	Clinical
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394211/ https://www.ncbi.nlm.nih.gov/pubmed/12838299 http://dx.doi.org/10.1038/sj.bjc.6600996

Ejemplares similares

Metastatic renal carcinoma comprehensive prognostic system
por: Atzpodien, J, et al.
Publicado: (2003)

Adjuvant treatment with interleukin-2- and interferon-alpha2a-based chemoimmunotherapy in renal cell carcinoma post tumour nephrectomy: Results of a prospectively randomised Trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN)
por: Atzpodien, J, et al.
Publicado: (2005)

Interleukin 10 (IL-10): an immunosuppressive factor and independent predictor in patients with metastatic renal cell carcinoma
por: Wittke, F, et al.
Publicado: (1999)

IL-2 in combination with IFN-αand 5-FU versus tamoxifen in metastatic renal cell carcinoma: long-term results of a controlled randomized clinical trial
por: Atzpodien, J, et al.
Publicado: (2001)

Interleukin-2/interferon-α2a/13-retinoic acid-based chemoimmunotherapy in advanced renal cell carcinoma: results of a prospectively randomised trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN)
por: Atzpodien, J, et al.
Publicado: (2006)

An approach to estimating prognosis using fractional polynomials in metastatic renal carcinoma
por: Royston, P, et al.
Publicado: (2006)

Quality of life in patients with advanced renal cell carcinoma treated with temsirolimus or interferon-α
por: Yang, S, et al.
Publicado: (2010)

The α Chemokine, Interleukin 8, Inhibits the Antiviral Action of Interferon α
por: Khabar, Khalid S.A., et al.
Publicado: (1997)

Cisplatin, gemcitabine, and treosulfan in relapsed stage IV cutaneous malignant melanoma patients
por: Atzpodien, J, et al.
Publicado: (2007)

Rapid onset renal deterioration in an adult with silent ureteropelvic junction obstruction
por: Hellenthal, Nicholas J., et al.
Publicado: (2009)

Use of rapid ferritin test to predict clinical deterioration in at home COVID-19 patients
por: Gandini, O., et al.
Publicado: (2021)

Rapid decline in kidney function is associated with rapid deterioration of health-related quality of life in chronic kidney disease
por: Kim, Hyo Jin, et al.
Publicado: (2023)

Interferon-α resistance in renal carcinoma cells is associated with defective induction of signal transducer and activator of transcription 1 which can be restored by a supernatant of phorbol 12-myristate 13-acetate stimulated peripheral blood mononuclear cells
por: Brinckmann, A, et al.
Publicado: (2002)

Rapid deterioration of renal function following coronavirus disease 2019 in a renal transplant recipient
por: Machiya, Seigo, et al.
Publicado: (2022)

Risk and outcome in metastatic malignant melanoma patients receiving DTIC, cisplatin, BCNU and tamoxifen followed by immunotherapy with interleukin 2 and interferon alpha2a.
por: Hoffmann, R., et al.
Publicado: (1998)

Survival in renal cell carcinoma: a randomized evaluation of tamoxifen vs interleukin-2, α-interferon (leucocyte) and tamoxifen
Publicado: (2000)

The cytokines interleukin-6 and interferon-α induce distinct microglia phenotypes
por: West, Phillip K., et al.
Publicado: (2022)

Survival in renal cell carcinoma: a randomized evaluation of tamoxifen vs interleukin-2, α-interferon (leucocytic) and tamoxifen – reply
Publicado: (2000)

Rapid deterioration of preexisting renal insufficiency after autologous mesenchymal stem cell therapy
por: Kim, Jun-Seop, et al.
Publicado: (2017)

Treatment of disseminated ocular melanoma with sequential fotemustine, interferon α, and interleukin 2
por: Becker, J C, et al.
Publicado: (2002)

Effect of Interleukin-29 on Interferon-α Secretion by Peripheral Blood Mononuclear Cells
por: Cho, Chi Hyun, et al.
Publicado: (2015)

A randomized phase II trial of interleukin 2 and interleukin 2-interferon alpha in advanced renal cancer.
por: Jayson, G. C., et al.
Publicado: (1998)

Immunochemotherapy with interleukin-2, interferon- α and 5-fluorouracil for progressive metastatic renal cell carcinoma: a multicenter phase II study
por: Herpen, C M L van, et al.
Publicado: (2000)

Myeloid cells promote interferon signaling-associated deterioration of the hematopoietic system
por: Feyen, Jacqueline, et al.
Publicado: (2022)

Quality of knee strengthening exercises performed at home deteriorates after one week
por: Mitchell, Ulrike H., et al.
Publicado: (2022)

Interferons and HIV Infection: The Good, the Bad, and the Ugly
por: Utay, Netanya S., et al.
Publicado: (2016)

Interferons in coronavirus pathogenesis: The good, the bad, and the ugly
por: Channappanavar, Rudragouda
Publicado: (2022)

Association between rapid renal function deterioration and cancer mortality in the elderly: A retrospective cohort study
por: Kuo, I‐Ching, et al.
Publicado: (2023)

Interleukin 12–dependent Interferon γ Production by CD8α(+)Lymphoid Dendritic Cells
por: Ohteki, Toshiaki, et al.
Publicado: (1999)

Immunomodulators: interleukins, interferons, and IV immunoglobulin
por: Roelofs, Joris J., et al.
Publicado: (2008)

The Deterioration of Vision during School Life
Publicado: (1904)

Providing a Home for Good
por: Young, Eugene R.
Publicado: (2023)

Interferon α Therapy in Patients with Chronic Hepatitis C Infection: Quality of Life and Depression
por: Conversano, Ciro, et al.
Publicado: (2015)

Two Roads Diverged: Interferon α/β– and Interleukin 12–mediated Pathways in Promoting T Cell Interferon γ Responses during Viral Infection
por: Cousens, Leslie P., et al.
Publicado: (1999)

Interferon-α versus interleukin-2 in Chinese patients with malignant melanoma: a randomized, controlled, trial
por: Li, Shenglong, et al.
Publicado: (2019)

Interleukin-6, tumour necrosis factor α and interleukin-1β in patients with renal cell carcinoma
por: Yoshida, N, et al.
Publicado: (2002)

Subcutaneous low-dose recombinant interleukin 2 and alpha-interferon in patients with metastatic renal cell carcinoma.
por: Ravaud, A., et al.
Publicado: (1994)

Reliability and life-cycle analysis of deteriorating systems
por: Sánchez-Silva, Mauricio, et al.
Publicado: (2016)

Signs of deterioration in infants discharged home following congenital heart surgery in the first year of life: a qualitative study
por: Tregay, Jenifer, et al.
Publicado: (2016)

Recognizing Early Deterioration in Elderly Care Home Setting - a Snapshot
por: Varvari, Ioana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a3nqbuii4v0am6r7nhtb4tgo2s